Abstract
Invasive Fungal Rhinosinusitis (IFRS) is a disease with low prevalence but profound impact due to its high mortality rate, ranging from 30-80% depending on the center and underlying conditions. It primarily affects immunocompromised patients, including those with diabetes, severe neutropenia, such as those in chemotherapy or bone marrow transplant (BMT) recipients. In these conditions, th…